Bax, a predictive marker for therapeutic response to preoperative chemoradiotherapy in patients with rectal carcinoma.

MLA

Chang, Hee Jin, et al. “Bax, a Predictive Marker for Therapeutic Response to Preoperative Chemoradiotherapy in Patients with Rectal Carcinoma.” Human Pathology, vol. 36, no. 4, Apr. 2005, pp. 364–71. EBSCOhost, https://doi.org/10.1016/j.humpath.2005.01.018.

APA

Chang, H. J., Jung, K. H., Kim, D. Y., Jeong, S.-Y., Choi, H. S., Kim, Y. H., Sohn, D. K., Yoo, B. C., Lim, S.-B., Kim, D.-H., Ahn, J.-B., Kim, I.-J., Kim, J. M., Yoon, W.-H., & Park, J.-G. (2005). Bax, a predictive marker for therapeutic response to preoperative chemoradiotherapy in patients with rectal carcinoma. Human Pathology, 36(4), 364–371. https://doi.org/10.1016/j.humpath.2005.01.018

Chicago

Chang, Hee Jin, Kyung Hae Jung, Dae Yong Kim, Seung-Yong Jeong, Hyo Seong Choi, Young Hoon Kim, Dae Kyung Sohn, et al. 2005. “Bax, a Predictive Marker for Therapeutic Response to Preoperative Chemoradiotherapy in Patients with Rectal Carcinoma.” Human Pathology 36 (4): 364–71. doi:10.1016/j.humpath.2005.01.018.